Mobocertinib price in India

It is understood that there is no Indian version of Mobocertinib (Mobocertinib) original drug or generic drug produced and marketed. The original drug of Mobocertinib may be on the market in India. Mobosetinib is a drug used to treat non-small cell lung cancer (NSCLC) and belongs to a class of drugs called tyrosine kinase inhibitors. It is specifically designed to target mutations in the EGFR (epidermal growth factor receptor) gene, especially in patients with non-small cell lung cancer with the T790M mutation. The price of the original drug Moboxetinib currently on the market in China is more than 40,000 yuan, which is very expensive. Cheaper generic drugs are sold overseas. For example, the Laos version has the specifications of 40mg*120 pills per box. The price is about three to four thousand yuan, which is nearly half cheaper than the original drug, and the original drug and the generic drug have the same ingredients.